Skip to main content

Advertisement

Table 3 Baseline characteristics of participants in the CAMPS trial

From: Trends and determining factors associated with adherence to antiretroviral therapy (ART) in Cameroon: a systematic review and analysis of the CAMPS trial

Variable Statistic
Age (years) : mean (SD) α 40.1 (10.10)
21-49 157 (79.3)
50+ 41 (20.7)
Gender: n (%)  
Female 147 (73.5)
Level of education: n (%)  
None or primary 78 (39.0)
Secondary or university 122 (61.0)
Family aware of HIV status: n (%) 180 (90.0)
Presence of an opportunistic infection: n(%) 62 (31.0)
BMI : mean (SD) β 25.2 (4.00)
Underweight 4 (2.2)
Normal 90 (48.6)
Overweight 91 (49.2)
CDC* classification - AIDS defining illness§:n (%) 146 (73.0)
Regimen: n (%) δ  
First line 179 (90.9)
Second line 18 (9.1)
Duration on ART (months): median (Q1, Q3) α 28.5 (9.0, 48.0)
CD4 (cells per mm 3 ): median (Q1, Q3) 336.0 (200.5,487.7)
Adherence  
Visual Analogue Scale: mean (SD)ε 90.5 (12.76)
Number of missed doses: mean (SD)μ 1.0 (0.00)
No missed doses: n (%) 127 (65.1)
Treatment taken on time: n (%) 108 (54.0)
Reasons for missing doses: n (%)  
Forgot 54 (27.0)
Out of home 23 (11.5)
Out of tablets 7 (3.5)
Too busy 8 (4.0)
Side effects 2 (1.0)
Other reason 5 (2.5)
Medication side effects experienced: n (%)  
None 127 (63.5)
One 43 (21.5)
Two 30 (15.0)
Reminder methods: n (%) ¥  
None 49 (25.7)
One 125 (65.4)
Multiple 17 (8.5)
  1. SD: standard deviation; BMI: body mass index; *Centres for Disease Control, § =CDC classifications: A3, B3, C1, C1, C3 [39]; α= 2missing; δ=3 missing; β=15 missing; ε= 10 missing ¥= 9missing; μ= 5 missing.
  2. The reminder methods reported were: personal verbal reminders by individuals, phone alarms, meal times, timing with TV shows and watches.